Method of using punicic acid to enhance immune response and prevent metabolic disorders
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A01N-035/00
A61K-031/12
출원번호
US-0710906
(2010-02-23)
등록번호
US-8258188
(2012-09-04)
발명자
/ 주소
Bassaganya-Riera, Josep
출원인 / 주소
Bassaganya-Riera, Josep
대리인 / 주소
Sara, Esq., Charles S.
인용정보
피인용 횟수 :
0인용 특허 :
6
초록▼
Disclosed is a method of enhancing the immune response of an animal, including mammals and humans, to prevent or ameliorate immunoinflammatory diseases such as Inflammatory Bowel Disease, increase immune system development, maintain or increase CD4+ and CD8+ T lymphocyte levels, increase immune func
Disclosed is a method of enhancing the immune response of an animal, including mammals and humans, to prevent or ameliorate immunoinflammatory diseases such as Inflammatory Bowel Disease, increase immune system development, maintain or increase CD4+ and CD8+ T lymphocyte levels, increase immune function, increase immune response against viruses and prevent or ameliorate the Metabolic Syndrome, Type 2 diabetes and obesity by administering orally or parenterally a therapeutically effective amount of punicic acid to the animal.
대표청구항▼
1. A method of treating an intestinal immunoinflammatory disorder comprising administering punicic acid to an animal suffering from the intestinal immunoinflammatory disorder in an amount effective to treat the intestinal immunoinflammatory disorder in the animal, wherein the amount is between about
1. A method of treating an intestinal immunoinflammatory disorder comprising administering punicic acid to an animal suffering from the intestinal immunoinflammatory disorder in an amount effective to treat the intestinal immunoinflammatory disorder in the animal, wherein the amount is between about 1 mg and 20 g per day. 2. The method of claim 1 wherein the immunoinflammatory disorder is Crohn's disease. 3. The method of claim 1 wherein the punicic acid is administered in free fatty acid form. 4. The method of claim 1 wherein the punicic acid is administered with a pharmaceutically acceptable carrier. 5. The method of claim 4 wherein the pharmaceutically acceptable carrier is suitable for a route of administration selected from the group consisting of parenteral administration, oral administration, and rectal administration. 6. The method of claim 1 wherein the punicic acid is administered in a pharmaceutical composition, a nutritional product, a food supplement, a foodstuff, or a food composition. 7. The method of claim 6 wherein the pharmaceutical composition is administered in the form of a tablet, a capsule, a cachet, a lozenge, a solution, or an emulsion. 8. The method of claim 1 wherein the immunoinflammatory disorder is inflammatory bowel disease. 9. The method of claim 1 wherein the immunoinflammatory disorder is ulcerative colitis. 10. A method of treating an immunoinflammatory disorder comprising administering punicic acid to an animal suffering from inflammatory bowel disease in an amount effective to treat the inflammatory bowel disease in the animal, wherein the amount is between about 1 mg and 20 g per day. 11. The method of claim 10 wherein the inflammatory bowel disease is Crohn's disease. 12. The method of claim 10 wherein the inflammatory bowel disease is ulcerative colitis. 13. The method of claim 10 wherein the punicic acid is administered in free fatty acid form. 14. The method of claim 10 wherein the punicic acid is administered with a pharmaceutically acceptable carrier. 15. The method of claim 14 wherein the pharmaceutically acceptable carrier is suitable for a route of administration selected from the group consisting of parenteral administration, oral administration, and rectal administration. 16. The method of claim 10 wherein the punicic acid is administered in a pharmaceutical composition, a nutritional product, a food supplement, a foodstuff, or a food composition. 17. The method of claim 16 wherein the pharmaceutical composition is administered in the form of a tablet, a capsule, a cachet, a lozenge, a solution, or an emulsion.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (6)
Shehadeh Ahmad Abdallah, Herbal extract composition and method with immune-boosting capability.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.